LLY vs NVO
Eli Lilly and Company vs Novo Nordisk A/S — AI-powered side-by-side comparison
LLY
Eli Lilly and Company
53
Watch
VS
NVO
Novo Nordisk A/S
50
Watch
| Metric | LLY | NVO |
|---|
| AI Score |
53
|
50
|
| Price |
$1,138.46
|
$41.73
|
| P/E Ratio |
38.04×
|
10.57×
|
| ROE |
77.8%
|
52.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
83.4%
|
80.6%
|
| Debt / Equity |
1.62×
|
0.63×
|
| Dividend Yield |
0.6%
|
4.2%
|
| RSI (14) |
40.1
|
27.7
|
| Beta |
0.502
|
0.349
|
| Expected Upside |
+9.8%
|
+12.3%
|
AI Committee View
Current Innellis committee reasoning for LLY versus NVO.
LLY leads by 3 points.
LLY scores 53/100 (Watch) versus NVO at 50/100 (Watch).
LLY Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 49.6% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 1.60) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 92.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 49.6% YoY -- genuine top-line momentum — Growth
- EPS growing 94.6% YoY — Growth
Bear Case
- P/E of 39.9 is moderate-to-rich — Value
- Price-to-book of 38.3x prices in significant intangible value — Value
- Debt-to-equity of 1.60 adds balance-sheet risk to the value case — Value
NVO Committee View
33% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.80 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 10.7 is inexpensive for the broad market — Value
- ROE of 59.1% shows genuine earnings power backing the valuation — Value
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Price-to-book of 7.4x prices in significant intangible value — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical